BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23271213)

  • 1. Primary gastrointestinal follicular lymphoma with histological transformation.
    Hangai S; Nakamura F; Kamikubo Y; Ichikawa M; Suzuki H; Yoshida S; Yamada A; Takazawa Y; Fukayama M; Koike K; Kurokawa M
    Ann Hematol; 2013 Jul; 92(7):993-4. PubMed ID: 23271213
    [No Abstract]   [Full Text] [Related]  

  • 2. [Follicular lymphoma showing long-term false positive results by FDG-PET after rituximab-containing chemotherapy].
    Miyazaki Y; Nawa Y; Kohashi S; Nakase K; Miyagawa M; Hara M
    Rinsho Ketsueki; 2012 Feb; 53(2):252-4. PubMed ID: 22450588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular complete remission of primary duodenal follicular lymphoma following treatment with rituximab and cyclophosphamide, vincristine and prednisone chemotherapy.
    Falorio S; Angrilli F; Fioritoni G
    Intern Med J; 2009 Oct; 39(10):706-7. PubMed ID: 19849763
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical analysis of eight patients with primary follicular lymphoma in the duodenum].
    Tsujioka T; Wada H; Yata K; Kondo T; Suemori S; Tokunaga H; Ohmori K; Kubo Y; Nakanishi H; Mikami M; Haruma K; Sadahira Y; Sugihara T
    Rinsho Ketsueki; 2007 Feb; 48(2):134-9. PubMed ID: 17370641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated diffuse large B cell lymphoma of bone on PET scan.
    Chen WL; Ho CL
    Int J Hematol; 2008 Jul; 88(1):1-2. PubMed ID: 18478313
    [No Abstract]   [Full Text] [Related]  

  • 6. Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial.
    Pardal E; Coronado M; Martín A; Grande C; Marín-Niebla A; Panizo C; Bello JL; Conde E; Hernández MT; Arranz R; Bargay J; González-Barca E; Pérez-Ceballos E; Montes-Moreno S; Caballero MD
    Br J Haematol; 2014 Nov; 167(3):327-36. PubMed ID: 25066542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hepatic (extranodal) lymphoma: utility of [(18)F]fluorodeoxyglucose-PET/CT.
    Seshadri N; Ananthasivan R; Kavindran R; Srikanth G; Chandra S
    Cancer Imaging; 2010 Oct; 10(1):194-7. PubMed ID: 20926362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS.
    Dupuis J; Berriolo-Riedinger A; Julian A; Brice P; Tychyj-Pinel C; Tilly H; Mounier N; Gallamini A; Feugier P; Soubeyran P; Colombat P; Laurent G; Berenger N; Casasnovas RO; Vera P; Paone G; Xerri L; Salles G; Haioun C; Meignan M
    J Clin Oncol; 2012 Dec; 30(35):4317-22. PubMed ID: 23109699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of follicular lymphoma].
    Izutsu K
    Rinsho Ketsueki; 2014 Oct; 55(10):1929-36. PubMed ID: 25297757
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
    Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications].
    Banzo J; Ubieto MA; Giraldo P; Razola P; Prats E; Tardin L; Santapau A; Parra A; Rambalde EF; Velilla J
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):89-92. PubMed ID: 21620527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
    Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K
    Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follicular lymphoma: 2012 update on diagnosis and management.
    Freedman A
    Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Systemic follicular lymphoma with cutaneous manifestations and exclusively cutaneous recurrence].
    Palacios Abufón A; Acebo Mariñas E; Gardeazabal García J; García-Ruiz JC
    Actas Dermosifiliogr; 2012 Apr; 103(3):253-5. PubMed ID: 22093542
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.
    Avigdor A; Sirotkin T; Kedmi M; Ribakovsy E; Berkowicz M; Davidovitz Y; Kneller A; Merkel D; Volchek Y; Davidson T; Goshen E; Apter S; Shimoni A; Ben-Bassat I; Nagler A
    Ann Hematol; 2014 Aug; 93(8):1297-304. PubMed ID: 24595734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of follicular lymphoma with onset of chylothorax].
    Hanaoka N; Nagao H; Murakami T; Chijiwa T; Suganuma T
    Nihon Kokyuki Gakkai Zasshi; 2007 Jan; 45(1):31-5. PubMed ID: 17313024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants.
    Trotman J; Fournier M; Lamy T; Seymour JF; Sonet A; Janikova A; Shpilberg O; Gyan E; Tilly H; Estell J; Forsyth C; Decaudin D; Fabiani B; Gabarre J; Salles B; Van Den Neste E; Canioni D; Garin E; Fulham M; Vander Borght T; Salles G
    J Clin Oncol; 2011 Aug; 29(23):3194-200. PubMed ID: 21747087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Occipital neuralgia (Arnold) as the presenting symptom of diffuse large B-cell non-Hodgkin lymphoma].
    Bruneau O; Le Moigne F; Guyotat J; Nicolas-Virelizier E; Guilloton L; Drouet A
    Rev Neurol (Paris); 2013 Feb; 169(2):175-8. PubMed ID: 23079854
    [No Abstract]   [Full Text] [Related]  

  • 19. A Bayesian approach to a patient with a residual mass after treatment for non-Hodgkin's lymphoma of the thyroid.
    Bibb J; Hromas R; Rabinowitz I
    J Clin Oncol; 2005 Dec; 23(34):8911-3. PubMed ID: 16314654
    [No Abstract]   [Full Text] [Related]  

  • 20. [Duodenal polyposis disclosing mantle-cell lymphoma].
    Moulin O; Boucher E; Samson T; Coutant G; Helie C; Algayres JP
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1055. PubMed ID: 12483144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.